BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17314004)

  • 1. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
    Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9.
    Yokota K; Shibata H; Kurihara I; Kobayashi S; Suda N; Murai-Takeda A; Saito I; Kitagawa H; Kato S; Saruta T; Itoh H
    J Biol Chem; 2007 Jan; 282(3):1998-2010. PubMed ID: 17105732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
    Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
    Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
    Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
    Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two independent SUMO-interacting motifs in Fas-associated factor 1 (FAF1): Implications for mineralocorticoid receptor (MR)-mediated transcriptional regulation.
    Wang CH; Hung PW; Chiang CW; Lombès M; Chen CH; Lee KH; Lo YC; Wu MH; Chang WC; Lin DY
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1282-1297. PubMed ID: 30935967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
    Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
    Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation.
    Le Drean Y; Mincheneau N; Le Goff P; Michel D
    Endocrinology; 2002 Sep; 143(9):3482-9. PubMed ID: 12193561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
    González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
    Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
    Subramanian L; Benson MD; Iñiguez-Lluhí JA
    J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.
    Dahle Ø; Andersen TØ; Nordgård O; Matre V; Del Sal G; Gabrielsen OS
    Eur J Biochem; 2003 Mar; 270(6):1338-48. PubMed ID: 12631292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylation.
    Guo Y; Yang MC; Weissler JC; Yang YS
    Biochem Biophys Res Commun; 2008 Sep; 374(3):570-5. PubMed ID: 18655774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11β-HSD2 SUMOylation Modulates Cortisol-Induced Mineralocorticoid Receptor Nuclear Translocation Independently of Effects on Transactivation.
    Jiménez-Canino R; Lorenzo-Díaz F; Odermatt A; Bailey MA; Livingstone DEW; Jaisser F; Farman N; Alvarez de la Rosa D
    Endocrinology; 2017 Nov; 158(11):4047-4063. PubMed ID: 28938454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
    Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription regulation of nuclear receptor PXR: Role of SUMO-1 modification and NDSM in receptor function.
    Priyanka ; Kotiya D; Rana M; Subbarao N; Puri N; Tyagi RK
    Mol Cell Endocrinol; 2016 Jan; 420():194-207. PubMed ID: 26549688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.
    Yan J; Yang XP; Kim YS; Joo JH; Jetten AM
    Biochem Biophys Res Commun; 2007 Oct; 362(1):132-138. PubMed ID: 17698038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein Gilz from proteasomal degradation and induces its binding to SUMO-1 in murine thymocytes.
    Delfino DV; Spinicelli S; Pozzesi N; Pierangeli S; Velardi E; Bruscoli S; Martelli MP; Pettirossi V; Falchi L; Kang TB; Riccardi C
    Cell Death Differ; 2011 Jan; 18(1):183-90. PubMed ID: 20671745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by sumoylation.
    Belaguli NS; Zhang M; Brunicardi FC; Berger DH
    PLoS One; 2012; 7(10):e48019. PubMed ID: 23118920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
    Kim EJ; Park JS; Um SJ
    Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stability.
    Manente AG; Pinton G; Tavian D; Lopez-Rodas G; Brunelli E; Moro L
    PLoS One; 2011; 6(10):e25676. PubMed ID: 21998680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.